Symptomatic Schistosoma mansoni: Infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy [4]

Clinical Infectious Diseases

Volumn 42, Issue 2, 2006, Pages 303-304

  De Silva, S ^a   Walsh, J ^c   Brown, Michael ^b  

^a Camden Primary Care Trust   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; PRAZIQUANTEL; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; CASE REPORT; CD4 LYMPHOCYTE COUNT; COLON BIOPSY; COLONOSCOPY; DIARRHEA; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LETTER; MALE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS LOAD; VOMITING;

ADULT; ANTHELMINTICS; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; MALE; SCHISTOSOMIASIS MANSONI;

EID: 30144445458     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499109     Document Type: Letter

References (8)

1. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38:1159-66.
2. Gardner EM, Connick E. Illness of immune reconstitution: recognition and management. Curr Infect Dis Rep 2004; 6:483-93.
3. Lucas S, Nelson AM. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people. In: Bloom B, ed. Tuberculosis: pathogenesis, protection and control. Washington, DC: ASM Press, 1994:503-13.
4. Lucas S, Musallam R, Bain J, Hassounah O, Bickle Q, Doenhoff M. The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetate. Trans R Soc Trop Med Hyg 1980; 74:633-43.
5. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 1997; 56:515-21.
6. Mwanakasale V, Vounatsou P, Sukwa T, Ziba M, Ernest A, Tanner M. Interaction between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg 2003; 69:420-8.
7. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. J Infect Dis 2005; 191:1311-20.
8. Brown M, Mawa P, Joseph S, et al. Treatment of Schistosoma mansoni increases helminth-specific type 2 cytokines and HIV-1 RNA concentrations in coinfected Ugandan adults. J Infect Dis 2005; 191:1648-57.